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Background: The COVID-19 pandemic has disrupted routine hospital services globally. This 
study estimated the total number of adult elective operations that would be cancelled worldwide 
during the 12 weeks of peak disruption due to COVID-19. 
Methods: A global expert-response study was conducted to elicit projections for the proportion 
of elective surgery that would be cancelled or postponed during the 12 weeks of  peak 
disruption. A Bayesian beta-regression model was used to estimate 12-week cancellation rates 
for 190 countries. Elective surgical case-mix data, stratified by specialty and indication (cancer 
versus benign surgery), was determined. This case-mix was applied to country-level surgical 
volumes. The 12-week cancellation rates were then applied to these figures to calculate total 
cancelled operations. 
Results: The best estimate was that 28,404,603 operations would be cancelled or postponed 
during the peak 12 weeks of disruption due to COVID-19 (2,367,050 operations per week). Most 
would be operations for benign disease (90.2%, 25,638,922/28,404,603). The overall 12-week 
cancellation rate would be 72.3%. Globally, 81.7% (25,638,921/31,378,062) of benign surgery, 
37.7% (2,324,069/6,162,311) of cancer surgery, and 25.4% (441,611/1,735,483) of elective 
Caesarean sections would be cancelled or postponed. If countries increase their normal surgical 
volume by 20% post-pandemic, it would take a median 45 weeks to clear the backlog of 
operations resulting from COVID-19 disruption. 
Conclusions A very large number of operations will be cancelled or postponed due to 
disruption caused by COVID-19. Governments should mitigate against this major burden on 
patients by developing recovery plans and implementing strategies to safely restore surgical 
activity.  











The COVID-19 pandemic has led to major disruption of routine hospital services globally1. 
During the pandemic hospitals have reduced elective surgery in the interests of patient safety 
and supporting the wider response2-4. Reducing elective activities protects patients from in-
hospital viral transmission and associated postoperative pulmonary complications. This 
preserves personal protective equipment (PPE) supplies to be prioritised for the care of COVID-
19 patients, and releases ward and critical care beds for surges in COVID-19 patients. It also 
enables recovery areas in theatre suites to be repurposed as overflow intensive care units. 
Surgeons and theatres teams may be redeployed to support other critical areas of the hospital. 
Cancelling elective surgery at this scale will have substantial impact on patients and cumulative, 
potentially devastating consequences for health systems worldwide5. Delaying time-sensitive 
elective operations, such as cancer or transplant surgery, may lead to deteriorating health, 
worsening quality of life, and unnecessary deaths6-8. When hospitals resume elective activities, 
patients are likely to be prioritised by clinical urgency9, resulting in lengthening delays for 
patients with benign but potentially disabling conditions where there may be less of a perceived 
time impact. This will lead to a deterioration in population health, productivity, and a substantial 
societal cost. 
Worldwide cancellations in elective surgery are currently unquantified10,11. Few countries have 
access to real time data, and even those that do may experience delays in this information 
being released due to pressures on health systems. Estimating country-level estimates will 
provide the best possible baseline data to inform planning for post-pandemic surgical recovery. 
This study aimed to estimate the total elective operations that would be cancelled or postponed 
worldwide during the 12 weeks of peak disruption of hospital services due to COVID-19. 
  











The methodology is summarised in Figure 1. Firstly, an expert response study was conducted to 
elicit surgeons’ projections for the proportion of elective surgery that would be cancelled during 
the peak 12 weeks of disruption due to COVID-19. This data was fed in to a Bayesian beta-
regression model to estimate 12-week cancellation rates for elective surgery for 190 countries. 
Secondly, elective surgical case-mix was determined for each Human Development Index (HDI) 
quintile using data from the Surgical Outcomes Studies and the expert response study. This 
case-mix was applied to existing figures for overall country-level surgical volume to calculate 
expected specialty-specific surgical volumes for 190 countries. Finally, these surgical volume 
figures and the 12-week cancellation rate estimates were used to calculate totals for cancelled 
operations by specialty and country. 
All 193 United Nations member countries were included in this study except Liechtenstein, 
North Korea, and Somalia, as there was no surgical volume data available for these three 
countries12. At present the only region to have recovered from a large-scale SARS-CoV-2 
outbreak is Hubei Province in China. Wuhan, the capital of Hubei, was in lockdown for 76 days 
(23 January 2020 to 8 April 2020). Therefore, the current best estimate for the duration of 
disruption to health systems caused by COVID-19 is around 12 weeks. This is consistent with 
advice that hospitals should plan to suspend non-urgent elective surgery for at least 12 weeks4. 
The secondary outcomes were total cancelled operations stratified by World Bank region 
(Europe and Central Asia, East Asia and Pacific, Latin America and the Caribbean, North 
America, Middle East and North Africa, South Asia, Sub-Saharan Africa), World Bank country 
income group (high, upper middle, lower middle, low income), and surgical specialty. Specialty-
specific cancellation totals were calculated for those surgical specialties accounting for 5% or 
more of global surgical case-mix (Supplementary Table 1). This included colorectal, head and 
neck, gynaecological, orthopaedic, obstetric, plastics, upper gastrointestinal (including 










hepatobiliary surgery), and urological surgery. Colorectal, head and neck, gynaecological, 
plastics, upper gastrointestinal, and urological surgery were further stratified in to operations 
performed for cancer versus benign pathology. Orthopaedic surgery was not stratified in this 
way as cancer accounts for a very small proportion of orthopaedic operations. Specialties that 
individually account for under 5% of surgical case-mix were pooled in to an ‘other surgery’ 
category, including breast surgery, cardiac surgery, neurosurgery, thoracic surgery, and 
vascular surgery. Therefore, a total of 15 specialty groups were included in this study (Table 1). 
12-week elective surgery cancellation rates 
Senior surgeons were invited to participate in an expert response study in order to elicit their 
projections for the proportion of elective surgery that would be cancelled during the peak 12 
weeks of disruption due to COVID-19. Surgeons were contacted through the global CovidSurg 
network and asked to enter their estimates in to an online database. The questionnaire was 
open from 20 march 2020 to 30 March 2020. 
Experts were asked to provide estimates for each of the 15 specialty groups included in this 
study. For each specialty group experts provided their best estimate (the most likely 12-week 
cancellation rate), as well as a lower bound estimate (the lowest possible cancellation rate) and 
an upper bound estimate (the highest possible cancellation rate). If the SARS-CoV-2 outbreak 
had resolved at the experts’ hospital, they were asked to report actual rates of cancelled surgery 
due to the outbreak. If the outbreak was ongoing, experts were asked to project likely 
cancellation rates forward. If the experts’ hospital had not yet experienced a SARS-CoV-2 
outbreak, they were asked to estimate what would happen in the event of an outbreak. 
After the expert response study questionnaire closed, responses were matched by hospital and 
in the cases of more than one expert participating per hospital, median values for each data 
point were calculated, so that there was one consolidated response per hospital. Overall median 
values for the best estimate and upper/ lower bounds were then calculated for each participating 










country for cancer surgery, benign surgery, and obstetric (elective Caesarean section) 
operations. 
A Bayesian beta-regression model was developed with 2018 Human Development Index (HDI) 
as a predictor, in order to establish 12-week cancellation rate estimates for all 190 countries 
included in the study (Supplementary Table 2). HDI is a composite index of life expectancy, 
education, and per capita income indicators and its relationship with surgical outcomes has 
previously been validated13,14. 
Non-informative priors were used with sensitivity analyses done on alternative priors and 
different chain initiation points or chain lengths. A restricted cubic spline transformation was 
applied to the continuous representation of the HDI rank (rank 1 being the most developed 
country and rank 190 being the least developed country) to account for potential non-linearity. 
This was substituted into the final beta regression model and posterior predictions were made 
for each HDI rank. The model was fitted for the best estimates and lower/ upper bounds for 
cancer surgery, benign surgery, and obstetric (Cesarean section) operations. 
Surgical case-mix 
The best available global data on surgical case-mix are from the African Surgical Outcomes 
Study (ASOS), European Surgical Outcomes Study (EuSOS), and International Surgical 
Outcomes Study (ISOS)15-17. These were prospective cohort studies that captured all adults 
undergoing surgery in participating facilities, providing case-mix data for a total of 102,539 
patients across 64 countries. No comparable global case-mix data exists for paediatric surgery, 
therefore, this study was limited to adults. 
Raw data from the three SOS studies were pooled to estimate case-mix by HDI quintile 
(Supplementary Table 2). First, the case-mix was determined according to urgency: elective 
versus emergency surgery. Next, within elective surgery the case-mix was stratified by 










specialty. In order to determine cancer surgery versus benign surgery case-mix, the expert 
response study participants were asked to estimate the proportions of colorectal, head and 
neck, gynaecological, plastics, upper gastrointestinal, and urological operations performed in 
their hospitals for cancer. Hospital-level results were then pooled by HDI quintile to calculate 
median proportions for cancer surgery for each specialty. 
Surgical volume 
A previous report identified total country surgical volume for 72 countries (presented as point 
estimates) and modelled estimates for a further 120 countries (presented as confidence 
intervals)12. As only overall total (paediatric surgery) country volumes were available, population 
age-structure data from the World Bank was used to estimate total adult surgical volume for 
each country. Adults were defined age 15 years and above, consistent with age categories used 
for population data by the World Bank.   
Country-level surgical volumes for each of the 15 specialty groups included in this study were 
calculated based on the country-specific adult surgical volume and case-mix for the appropriate 
HDI quintile. For the best estimate of total cancellations, the point estimate (if provided) or the 
midpoint of the confidence interval for country-level surgical volume were used in order to 
calculate specialty-specific country-level surgical. 
Totals for cancelled surgery 
Country-level surgical volume data and modelled 12-week cancellation rates were used to 
calculate specialty group-specific totals for adult elective operations cancelled during the peak 
12 weeks of disruption. The best estimate for the number of cancelled operations was based on 
the modelled best estimates for 12-week cancellation rates. 
Surgical recovery 










The time it would take countries to clear the backlog of operations resulting from 12 weeks of 
disruption due to COVID-19 was estimated. It was assumed that cancelled obstetric (Cesarean 
section) operations would not need to be rescheduled post-pandemic. Therefore, the time taken 
to clear country-level backlogs of operations for benign disease and cancer was based country-
level baseline volumes of surgery for benign disease and cancer. The number of whole or part 
weeks needed to clear these backlogs was caclulated based on 10%, 20%, and 30% increases 
in baseline surgical volume. 
Sensitivity analyses 
An estimate for the minimum operations likely to be cancelled was based on the lowest likely 
baseline surgical volume (i.e. the lower bounds for total surgical volume estimates where 
provided) and the modelled lower bounds for 12-week cancellation rates. An estimate for the 
maximum operations likely to be cancelled was based on the highest likely baseline surgical 
volume (i.e. the upper bounds for total surgical volume estimates where provided) and modelled 
upper bounds for 12-week cancellation rates. 
Analyses were done using the R Foundation Statistical Program version 3.6.3 and rstan (the R 
interface to the statistical inference language Stan) and the packages brms and finalfit. 











12-week cancellation rates 
From a total of 538 submissions to the expert response study (Supplementary Figure 1), data 
was available for 359 hospitals in 71 countries (Supplementary Table 3). Proportions of surgery 
projected to be cancelled were consistently estimated to be higher for benign surgery than for 
obstetrics (elective Caesarean sections). Proportions of cancer surgery projected to be 
cancelled were lower in the most developed countries compared to the least developed 
countries (Supplementary Figure 2). 
Based on the Bayesian beta-regression model, best estimates for country-level 12-week 
cancellation rates (Supplementary Table 4) for cancer surgery ranged 23.4-77.1%, whilst they 
ranged 71.2-87.4% for benign surgery, and 17.4%-37.8% for obstetrics (Figure 2).  
Surgical volume 
The best estimate for cancellations was based on a global annual adult elective surgical volume 
of 170,195,382 operations (Supplementary Figure 3). Details of surgical case-mix are provided 
in Supplementary Table 5-8 and Supplementary Figures 4-7. 
Total cancellations 
The best estimate was that globally 28,404,603 operations would be cancelled or postponed 
during the peak 12 weeks of the COVID-19 pandemic. Worldwide 2,367,050 operations would 
be cancelled per week, with 11 countries cancelling more than 50,000 operations per week 
(Table 2). 
Most of the cancelled or postponed operations were estimated to be benign surgeries (90.2%, 
25,638,922/28,404,603), followed by cancer surgeries (8.2%, 2,324,070/28,404,603), and 
obstetrics (1.6%, 441,611/28,404,603, Table 1). The best estimate was that the global 12-week 
cancellation rates would be 72.3% (28,404,603/39,275,857) overall, 81.7% 










(25,638,921/31,378,062) for benign surgery, 37.7% (2,324,069/6,162,311) for cancer surgery, 
and 25.4% (441,611/1,735,483) for obstetrics (Table 3). 
Overall 12-week cancellation rates by World Bank region would range from 68.3% to 73.0%. 
The most cancellations were projected to take place in Europe and Central Asia (n=8,430,348, 
Figure 3) and the least in Sub-Saharan Africa (n=520,458, Table 4), reflecting the low baseline 
surgical volume there. Country-level totals stratified by specialty are presented in 
Supplementary Table 9. 
Surgical recovery 
It was estimated that based on a 20% increase in baseline surgical volume it would take 
countries a median of 45 weeks (range: 43-48 weeks) to clear the backlog of operations 
resulting from 12 weeks of disruption due to COVID-19 (Supplementary Table 10). If baseline 
surgical volume was increased by 10% it would take countries a median of 90 weeks (range: 
86-95) weeks to clear the backlog, whereas with a 30% increase in baseline surgical volume 
this would take a median of 30 weeks (range: 29-32). 
Sensitivity analyses 
The minimum estimate was that 19,849,153 operations would be cancelled worldwide during 
the 12 weeks of peak disruption due to COVID-19 (1,654,096 per week), representing a 61.1% 
(19,849,153/32,488,250) 12-week cancellation rate. The maximum estimate was that 
43,945,672 operations would be cancelled during the peak 12 weeks (3,662,139 per week), 
representing a 86.2% (43,945,672/50,960,625) 12-week cancellation rate. 
  











This study demonstrates the major burden of cancelled elective surgery due to the COVID-19 
pandemic. Although a similar proportion of surgery will be cancelled across different country-
income settings and geographic regions, the greatest number of cancellations will be in upper 
middle-income countries. Cancer surgery will be prioritised in most settings, with most 
cancellations relating to surgery for benign conditions, most frequently orthopaedics.  
The risks of exposing patients to perioperative SARS-CoV-2 infection by performing surgery 
during outbreaks are high, but must be weighed against the risks of protracted treatment delays. 
Given that many health systems already lack sufficient capacity to meet the need for surgery18, 
the impact of cancellations will be cumulative, adding to existing waiting lists. Governments will 
need to fund substantial increases in baseline surgical volume to clear backlogs, but this is likely 
to be costly. For example, based on an average cost of £4,000 per operation, it would cost over 
£2 billion to clear the United Kingdom's backlog. 
There is a risk that delayed treatment of benign conditions as a result of pandemic-related 
cancellations will lead to deterioration in individual patients’ conditions, increasing disability and 
reducing their ability to work. This will lead to lead to substantial societal costs, particularly in 
LMICs where catastrophic expenditure relating to surgical disease can lead to 
impoverishment19,20. 
This study has several limitations. Whilst estimates were based on the best available global 
surgical data, several assumptions were required. As the COVID-19 pandemic is ongoing it was 
necessary for the expert response study participants to project forward their estimates for 12-
week cancellation rates. Participants in countries where the pandemic was in its earliest stages, 
such as in Sub-Saharan Africa, may had to base their estimates on experience in previous 
emergencies, rather than the specific circumstances of COVID-19. The uncertainty around 
these estimates was captured by recording both lower and upper bounds, as well as best 










estimates for 12-week cancellation rates. Surgical case-mix was principally based on snapshot 
cohort studies that collected data across 64 countries15-17. Given the barriers to participation in 
research, particularly in LMICs21, it is unknown how representative this data is for global case-
mix. Most countries do not publish surgical volume data so this study relied on previous 
estimates of country-level surgical volume.  
The eventual geographic extent and intensity of the pandemic is currently unknown, but it is 
likely that most countries will be effected22-24. The country-level figures can be used to produce 
estimated of per-week cancellations, allowing policy makers to adjust estimates according to the 
predicted duration of local outbreaks. Prediction of the impact of COVID-19 on elective surgery 
in local communities can inform local planning and resource prioritisation. 
Post-pandemic surgical recovery planning should anticipate the possibility of repeat waves of 
SARS-CoV-2 infection25, leading to additional periods of cancellation of elective surgery. 
Therefore, strategies to safely maintain surgical volume during and immediately following 
SARS-CoV-2 outbreaks should be explored. For example, time-sensitive surgery, such as 
cancer resection, can be performed in designated non-COVID-19 units which do not treat 
COVID-19 patients. Although the optimal organisation of such surgical units is unknown, it is 
likely that they should carefully select low-risk patients who are unlikely to require intensive care 
and can be safely operated in satellite units. Both patients and staff will require rigorous 
screening to reduce the risks of cross-infection. Surgical recovery plans should also consider 
that an immediate return to high volume surgery may not be possible. For example, adaptations 
to operating theatres, such as installation of negative pressure flow systems, may need to be 
expedited in order to reduce the delay to resumption of normal activity. 
Future research should be prioritised to identify strategies to mitigate the risk of operating in 
COVID-19 environments, so that cancellations are minimised. For example, whilst ongoing trials 










are testing treatments for COVID-1926-28, large randomised trials are also needed to test 
therapies to prevent postoperative COVID-19 pulmonary complications. 
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Table 1: Best estimates of cancelled operations over a 12-week period of peak disruption, 
by specialty group 
 
Specialty group Normal volume Estimated cancellations 12-week cancellation rate 
Cancer surgery 
Colorectal 1,353,952 486,563 35.9% 
Gynaecology 834,839 328,505 39.3% 
Head & neck 959,190 373,603 38.9% 
Plastics 505,294 178,362 35.3% 
Upper gastrointestinal and hepatobiliary 1,258,862 498,885 39.6% 
Urology 1,250,175 458,151 36.6% 
Benign surgery 
Colorectal 1,201,825 976,992 81.3% 
Gynaecology 2,665,361 2,175,774 81.6% 
Head & neck 4,845,604 3,950,551 81.5% 
Orthopaedics 7,677,515 6,295,041 82.0% 
Plastics 933,822 764,033 81.8% 
Upper gastrointestinal and hepatobiliary 2,728,786 2,223,194 81.5% 
Urology 3,051,523 2,492,604 81.7% 
Other 8,273,626 6,760,731 81.7% 
Obstetrics 
Obstetrics 1,735,483 441,611 25.4% 
Total 39,275,857 28,404,603 72.3% 
 
Normal volume relates to surgical volume at full capacity (no cancellations)  
  










Table 2: Weekly totals for best estimates of cancelled operations, by country 
 
<1,000 Albania (567), Andorra (41), Antigua and Barbuda (54), Bahamas, The (280), Bahrain (514), Barbados (193), 
Belize (57), Benin (157), Bhutan (103), Botswana (792), Brunei Darussalam (249), Burkina Faso (237), Burundi 
(110), Cabo Verde (49), Cambodia (601), Cameroon (744), Central African Republic (32), Chad (29), Comoros 
(24), Congo, Dem. Rep. (642), Congo, Rep. (155), Cyprus (347), Djibouti (45), Dominica (27), Equatorial 
Guinea (211), Eritrea (78), Eswatini (195), Fiji (175), Gabon (242), Gambia, The (30), Grenada (43), Guinea 
(141), Guinea-Bissau (35), Guyana (93), Haiti (305), Honduras (974), Iceland (297), Jamaica (964), Kiribati (7), 
Kyrgyz Republic (877), Lao PDR (192), Lesotho (115), Liberia (168), Luxembourg (564), Madagascar (231), 
Malawi (283), Maldives (237), Mali (347), Malta (554), Marshall Islands (16), Mauritania (116), Mauritius (260), 
Micronesia, Fed. Sts. (22), Monaco (32), Montenegro (268), Mozambique (370), Namibia (497), Nauru (7), 
Nepal (277), Niger (206), North Macedonia (711), Palau (15), Papua New Guinea (338), Rwanda (349), Samoa 
(13), San Marino (16), Sao Tome and Principe (18), Senegal (267), Seychelles (232), Sierra Leone (110), 
Solomon Islands (55), South Sudan (135), St. Kitts and Nevis (33), St. Lucia (76), St. Vincent and the 
Grenadines (36), Suriname (243), Tajikistan (680), Tanzania (808), Timor-Leste (48), Togo (137), Tonga (26), 




Afghanistan (1048), Angola (1612), Armenia (1124), Azerbaijan (1556), Bangladesh (2671), Bolivia (1094), 
Bosnia and Herzegovina (1625), Bulgaria (5109), Costa Rica (1734), Cote d'Ivoire (1153), Croatia (2086), 
Cuba (5578), Czech Republic (6531), Denmark (5622), Dominican Republic (3934), Ecuador (2012), Egypt, 
Arab Rep. (9055), El Salvador (1200), Estonia (1255), Ethiopia (1124), Finland (6053), Georgia (1868), Ghana 
(1212), Greece (7492), Guatemala (1119), Iraq (3420), Ireland (1376), Israel (3766), Jordan (1839), 
Kazakhstan (7339), Kenya (1780), Kuwait (2593), Latvia (3565), Lebanon (2717), Libya (2060), Lithuania 
(2945), Moldova (1564), Mongolia (1283), Morocco (1302), Myanmar (1674), New Zealand (2721), Nicaragua 
(1351), Nigeria (9543), Norway (5370), Oman (1005), Pakistan (3746), Panama (2409), Paraguay (2211), Peru 
(7478), Portugal (8885), Qatar (1933), Romania (9135), Saudi Arabia (9410), Serbia (3476), Singapore (4418), 
Slovak Republic (4644), Slovenia (1524), Sri Lanka (3509), Sudan (3485), Switzerland (9162), Syrian Arab 
Republic (1697), Tunisia (3501), Turkmenistan (1208), United Arab Emirates (6402), Uruguay (2292), 
Uzbekistan (6988), Vietnam (7110) 
10,000-
49,999 
Algeria (12870), Argentina (27088), Austria (11967), Belarus (17569), Belgium (22660), Canada (32881), Chile 
(11696), Hungary (13959), India (48728), Indonesia (31050), Iran, Islamic Rep. (32099), Korea, Rep. (17267), 
Malaysia (12891), Mexico (15315), Netherlands (15847), Philippines (13593), Poland (22656), South Africa 
(12795), Spain (45449), Sweden (14588), Thailand (18332), Ukraine (21943), United Kingdom (43307), 
Venezuela, RB (17234) 
50,000-
99,999 
Australia (67149), France (58708), Germany (75730), Italy (50552), Russian Federation (93688), Turkey 
(82002) 
≥100,000 Brazil (247444), China (326177), Colombia (113082), Japan (113324), United States (343670) 
 
Weekly total for cancelled operations indicated in parentheses. 
  










Table 3: Best estimates for cancelled operations over a 12-week period of peak 
disruption, by country-income and region 
 
 
Benign surgery Cancer surgery Obstetrics Total 
High income 11,803,371 (83.6%) 937,740 (30.3%) 89,073 (20.1%) 12,830,185 (72.7%) 
East Asia and Pacific 2,276,604 (84.6%) 167,830 (28.7%) 17,271 (21.7%) 2,461,704 (73.4%) 
Europe and Central Asia 4,895,041 (83.7%) 384,630 (30%) 39,106 (20.9%) 5,318,777 (72.7%) 
Latin America and the Caribbean 188,143 (81.7%) 22,331 (38.7%) 3,718 (23.4%) 214,192 (70.5%) 
Middle East and North Africa 284,896 (83%) 26,142 (33.9%) 3,076 (23.3%) 314,114 (72.4%) 
North America 4,156,253 (83.1%) 336,510 (31%) 25,855 (17.5%) 4,518,619 (72.4%) 
Sub-Saharan Africa 2,434 (81%) 297 (39.5%) 47 (22.7%) 2,778 (70%) 
Upper middle income 11,824,165 (80.4%) 1,171,864 (43.4%) 254,374 (26.4%) 13,250,403 (72.1%) 
East Asia and Pacific 3,836,777 (79.6%) 370,906 (47.8%) 83,989 (27.9%) 4,291,672 (72.8%) 
Europe and Central Asia 2,402,694 (81.5%) 277,144 (37.8%) 47,108 (23.2%) 2,726,946 (70.2%) 
Latin America and the Caribbean 4,811,770 (80.6%) 436,109 (43.6%) 101,324 (26.9%) 5,349,203 (72.8%) 
Middle East and North Africa 579,884 (80.4%) 67,302 (44.5%) 12,885 (24.9%) 660,070 (71.4%) 
South Asia 38,931 (82.1%) 5,227 (45.1%) 798 (24.6%) 44,957 (72.2%) 
Sub-Saharan Africa 154,110 (77.7%) 15,176 (55.6%) 8,270 (28.4%) 177,555 (69.7%) 
Lower middle income 1,906,718 (78.8%) 200,315 (56.8%) 86,875 (29.5%) 2,193,909 (71.6%) 
East Asia and Pacific 591,840 (79.5%) 63,188 (55.3%) 16,827 (28.6%) 671,855 (73.2%) 
Europe and Central Asia 338,114 (80.8%) 31,754 (48.3%) 6,595 (24.4%) 376,463 (73.7%) 
Latin America and the Caribbean 47,844 (76.7%) 4,839 (57.8%) 2,749 (28.8%) 55,433 (69.1%) 
Middle East and North Africa 144,904 (77.7%) 14,644 (56%) 7,282 (29.9%) 166,830 (70.4%) 
South Asia 571,190 (79%) 58,633 (60.1%) 33,156 (28.9%) 662,980 (70.9%) 
Sub-Saharan Africa 212,826 (75.1%) 27,257 (67.8%) 20,266 (33.7%) 260,349 (67.8%) 
Low income 104,668 (75.1%) 14,150 (70.2%) 11,289 (34.6%) 130,106 (67.7%) 
Europe and Central Asia 7,055 (78.6%) 689 (57.2%) 418 (30.4%) 8,162 (70.7%) 
Latin America and the Caribbean 2,900 (72.1%) 405 (69.1%) 355 (36.5%) 3,660 (65.6%) 
Middle East and North Africa 18,259 (77.3%) 2,415 (70.2%) 1,941 (34%) 22,615 (69%) 
South Asia 12,872 (75.2%) 1,710 (69.8%) 1,311 (34.4%) 15,892 (68%) 
Sub-Saharan Africa 63,582 (74.2%) 8,931 (71.6%) 7,264 (35.1%) 79,777 (67.1%) 
 
Cancellation rate during the 12 weeks of peak disruption due to COVID-19 is indicated in 
parentheses 
  










Table 4: Projected totals of cancelled operations over a 12-week period of peak distruption, by specialty and region 
 
  Europe and Central Asia East Asia and Pacific 
Latin America 
and the 
Caribbean North America 
Middle East 
and North 































































































































































































































Main figures represent the best estimates; minimum and maximum estimates are indicated in parentheses 
  










Figure 1: Flowchart of methodology 
 
  
Data from expert response study fed in to Bayesian beta-
regression model to estimate cancellation rates for elective 
cancer surgery, benign surgery, and obstetrics for 190 
countries
Projections for proportions of elective cancer surgery, 
benign surgery, and obstetric procedures that will be 
cancelled during the peak 12 months of disruption due to 
COVID-19 elicited from expert response study
Elective surgical case-mix (colorectal, head and neck, 
obstetric and gynaecological, orthopaedic, plastic, upper 
gastrointestinal, urological, and other surgery) determined
for each HDI quintile based on data collected across 64 
countries by the Surgical Outcomes Studies
Case-mix estimates refined based on surgeons’ estimates 
from the expert response study for the proportion of 
colorectal, head and neck, gynaecological, plastic, upper 
gastrointestinal, and urological procedures performed for 
cancer
Case-mix estimates and previous figures for overall surgical 
volume (Holmer et al) used to calculate absolute volumes of 
adult elective surgery performed per-country by specialty
Country-level surgical volume data and modelled cancellation rates were used to calculate totals for adult elective operations cancelled during the 
peak 12 weeks of disruption due to COVID-19, and stratified by World Bank region, World Bank country income group, and specialty. 
Cancellation rates for elective surgery by country Absolute volumes of elective surgery by country










Figure 2: Country-level 12-week cancellation rates, by type of surgery 
 
Figure 2(a): Benign surgery 
 
  
























Figure 2(c): Obstetrics 
 
  










Figure 3: Best estimates for elective operations cancelled during the peak 12 weeks of 




Elective operations performed are those that are projected not to be cancelled during the 12 
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